Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

hahnemann laboratories, inc. - strontium iodide (unii: f6v5hor0o5) (strontium iodide - unii:f6v5hor0o5) -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

hahnemann laboratories, inc. - strontium (unii: yzs2rpe8le) (strontium - unii:yzs2rpe8le) -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

hahnemann laboratories, inc. - strontium phosphate (unii: b7cf3bd0tt) (strontium cation - unii:37077s2c93) -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

hahnemann laboratories, inc. - strontium (unii: yzs2rpe8le) (strontium - unii:yzs2rpe8le) -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

hahnemann laboratories, inc. - strontium chloride hexahydrate (unii: o09usb7z44) (strontium cation - unii:37077s2c93) -

Iisrael - inglise - Ministry of Health

eldan electronic instruments co ltd - strontium (89sr) chloride - solution for injection - strontium (89sr) chloride 150 mbq / 4 ml - strontium (89sr) chloride - strontium (89sr) chloride - adjunct and alternative to external beam radiotherapy for palliation of pain from bone metastases secondary to prostatic carcinoma at the stage of hormone therapy failure.

Euroopa Liit - inglise - EMA (European Medicines Agency)

les laboratoires servier - strontium ranelate - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of severe osteoporosis in postmenopausal women at high risk for fracture to reduce the risk of vertebral and hip fractures.treatment of severe osteoporosis in adult men at increased risk of fracture.the decision to prescribe strontium ranelate should be based on an assessment of the individual patient's overall risks.

Euroopa Liit - inglise - EMA (European Medicines Agency)

les laboratoires servier - strontium ranelate - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of severe osteoporosis in postmenopausal women at high risk for fracture to reduce the risk of vertebral and hip fractures. treatment of severe osteoporosis in adult men at increased risk of fracture. the decision to prescribe strontium ranelate should be based on an assessment of the individual patient's overall risks.,

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - strontium chloride, quantity: 100 mg/g - paste - excipient ingredients: glycerol; sorbitol solution (70 per cent) (non-crystallising); hyetellose; calcium carbonate; titanium dioxide; purified water; peppermint oil; silicon dioxide; erythrosine; peg-40 stearate; sodium methyl cocoyl taurate; methyl hydroxybenzoate; saccharin sodium; propyl hydroxybenzoate - prevention of dental caries. protection against dental hypersensitivity. maintenance of dental hygiene.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

sterling-knight pharmaceuticals, llc - esomeprazole strontium (unii: c5n25h3803) (esomeprazole - unii:n3pa6559ft) - healing of erosive esophagitis esomeprazole strontium is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole strontium may be considered. maintenance of healing of erosive esophagitis esomeprazole strontium is indicated to maintain symptom resolution and healing of erosive esophagitis. controlled studies do not extend beyond 6 months. symptomatic gastroesophageal reflux disease esomeprazole strontium is indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults. esomeprazole strontium is indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy in patients at risk for developing gastric ulcers. patients are considered to be at risk either due to their age (≥60) and/or documented history of gastric ul